Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure Yahoo FinanceEli Lilly reports outcomes from Phase III trial of tirzepatide for HFpEF Yahoo FinanceEli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free Reuters.comTirzepatide Reduces Heart Failure Events in HFpEF With Obesity MedscapeTirzepatide yields sustained weight reduction in obesity and prediabetes, finds study Medical Xpress